DOI: 10.36347/sasjm.2020.v06i02.009

Pages: 61-66

The applications of nuclear medicine in cardiology began in January 2017 at the University Hospital of Marrakech with the use of myocardial scintigraphy. Stress tests were coupled to the study of perfusion and myocardial function. After few months of operation, we propose to determine the contribution of myocardial scintigraphy in the assessment of cardiac pathologies at the Mohamed VI University Hospital Center in Marrakech. This is a retrospective descriptive study that took place from January 04, 2017 to November 04, 2019. One hundred and twenty one patients were included in the study; they all presented a cardiac disease and underwent a myocardial scintigraphy. Men were the most represented (83%) and the average age was 55 years old. The majority of patients (77%) had at least one cardiovascular risk factor. The diagnosis of coronary artery disease was the most important indication for myocardial scintigraphy (54%). 105 patients underwent a physical effort test according to the modified Bruce protocol, followed by a myocardial scintigraphy and then an examination at rest, the Dipyridamole protocol was performed in 16 patients. Ischemic heart disease was diagnosed in 33 of our study group (27.27%). The integration of myocardial scintigraphy in the assessment of heart diseases could contribute to a better management of our patients and to an early diagnosis of ischemia in asymptomatic patients.